Oxford Cancer Biomarkers develops proprietary biomarker technologies aimed at supporting clinical decision-making in cancer diagnosis and treatment, self-described as revolutionary in cancer clinical decision medicine.
peer of
Metrics
marketPRIVATE
msh_idCOM:OXFORDBIO
localegb
websitehttps://oxfordbio.com
source_refdc120721-89e1-472f-aa0b-8e5be321efc0
products_or_servicesBiomarker technologies for cancer diagnosis and treatment, including tests for chemotherapy toxicity and risk profiling for colorectal cancer.
United Kingdom